Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis

NCT06021743 is registered in ClinicalTrials.gov with University Hospital for Infectious Diseases, Croatia as lead sponsor.

NCT NCT06021743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06021743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis
Lead sponsor
University Hospital for Infectious Diseases, Croatia
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
March 1, 2024
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune response, sepsis, steatosis of liver